Paper42873441PubMed
Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents.
Shin L and 2 others. Curr Pain Headache Rep, 2026.
Cite this record
ConductScience Library. Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents. Papers, record 42873441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42873441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Current Evidence on the Use of Calcitonin Gene-Related Peptide-Targeting Therapies in Children and Adolescents.
- Journal
- Curr Pain Headache Rep
- Year
- 2026
- Publication types
- Journal Article, Review
- Revised in PubMed
- 2026-10-17
Source PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Calcitonin Gene-Related Peptide | Major topic |
| Migraine Disorders | Major topic |
| Humans | |
| Child | |
| Adolescent | |
| Antibodies, Monoclonal, Humanized | |
| Antibodies, Monoclonal |
Source PubMed
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36788886 | Monoclonal Antibodies Against the Calcitonin Gene-Related Peptide and Its Receptor in Japanese Adolescents With Migraines. | Cureus | 2023 | https://conductscience.org/library/papers/36788886 | PubMed |
| 2 | 31800988 | Ubrogepant for the Treatment of Migraine. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31800988 | PubMed |
| 3 | 30733702 | Plasma Calcitonin Gene-Related Peptide: A Potential Biomarker for Diagnosis and Therapeutic Responses in Pediatric Migraine. | Front Neurol | 2019 | https://conductscience.org/library/papers/30733702 | PubMed |
| 4 | 31291515 | Trial of Galcanezumab in Prevention of Episodic Cluster Headache. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31291515 | PubMed |
| 5 | 36587297 | Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache. | Cephalalgia | 2023 | https://conductscience.org/library/papers/36587297 | PubMed |
| 6 | 35690723 | European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention - 2022 update. | J Headache Pain | 2022 | https://conductscience.org/library/papers/35690723 | PubMed |
| 7 | 15836598 | The placebo responder rate in children and adolescents. | Headache | 2005 | https://conductscience.org/library/papers/15836598 | PubMed |
| 8 | 1699472 | Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. | Ann Neurol | 1990 | https://conductscience.org/library/papers/1699472 | PubMed |
| 9 | 8388188 | The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. | Ann Neurol | 1993 | https://conductscience.org/library/papers/8388188 | PubMed |
| 10 | 36633118 | Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review. | Headache | 2023 | https://conductscience.org/library/papers/36633118 | PubMed |
| 11 | 31550910 | CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice. | Cephalalgia | 2019 | https://conductscience.org/library/papers/31550910 | PubMed |
| 12 | 23109652 | Migraine and migraine subtypes in preadolescent children: association with school performance. | Neurology | 2012 | https://conductscience.org/library/papers/23109652 | PubMed |
| 13 | 7518321 | Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. | Brain | 1994 | https://conductscience.org/library/papers/7518321 | PubMed |
| 14 | 32003253 | Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting. | Expert Opin Ther Targets | 2020 | https://conductscience.org/library/papers/32003253 | PubMed |
| 15 | 41235617 | Gepants for headache prevention in children and adolescents: A multicenter chart review study. | Headache | 2026 | https://conductscience.org/library/papers/41235617 | PubMed |
| 16 | 29171821 | A Controlled Trial of Erenumab for Episodic Migraine. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29171821 | PubMed |
| 17 | 37979595 | Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA. | Lancet | 2023 | https://conductscience.org/library/papers/37979595 | PubMed |
| 18 | 29848108 | Efficacy and safety of galcanezumab for the prevention of episodic migraine: Results of the EVOLVE-2 Phase 3 randomized controlled clinical trial. | Cephalalgia | 2018 | https://conductscience.org/library/papers/29848108 | PubMed |
| 19 | 28176234 | Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system. | J Headache Pain | 2017 | https://conductscience.org/library/papers/28176234 | PubMed |
| 20 | 41534042 | Fremanezumab in Children and Adolescents with Episodic Migraine. | N Engl J Med | 2026 | https://conductscience.org/library/papers/41534042 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42873441
GET https://conductscience.org/api/papers/v1/42873441/references?page=2